Literature DB >> 36172620

Antibiotics Resistance Prevalence of Helicobacter pylori Strains in Northwest China.

Huimei Xu1, Jianwei Yun1, Ruiying Li1, Xueni Ma1, Lingzhu Gou1, Tuanjie Che2, Dekui Zhang1,3.   

Abstract

Purpose: This study aims to estimate the resistance rate of Helicobacter pylori (HP) to commonly used antibiotics and analyze the potential influencing factors in northwest regions of China. Patients and
Methods: HP-positive patients visiting the outpatient department of multiple hospitals were enrolled in the study. Then, gastric mucosal biopsy specimens were collected for HP isolation, culture, and investigation of the resistance rate of HP to amoxicillin, metronidazole, tetracycline, levofloxacin, and clarithromycin by Epsilometer test (E-test) antibiotic susceptibility testing. In addition, multi-drug resistance, the influence of HP eradication history, age, and region of residence on drug resistance rate were analyzed.
Results: In total, 198 HP clinical strains were successfully isolated and cultured. The resistance rates of amoxicillin, metronidazole, tetracycline, levofloxacin, and clarithromycin were 16.16%, 85.86%, 7.58%, 46.46%, and 55.05%, respectively. The multi-drug resistance rates demonstrated that dual and triple resistances were 30.30% and 22.73%, respectively. The quadruple resistance rate reached 9.60%. Our results revealed that the prior eradication history of HP significantly increased levofloxacin and clarithromycin resistance. Metronidazole and levofloxacin resistances significantly differed among different age groups, which presented an upward trend with increasing age. Drug resistance rates varied with geographic regions, especially amoxicillin and clarithromycin resistance, which were highest in Hexi Corridor and Longnan regions.
Conclusion: The current situation of HP resistance to common antibiotics is severe. Tetracycline is the most sensitive antibiotic, followed by amoxicillin, the first choice for HP eradication. However, the eradication failure of HP may lead to an increase in the resistance rate. Therefore, it is necessary to strengthen the standardized diagnosis and treatment of HP to improve the primary eradication rate.
© 2022 Xu et al.

Entities:  

Keywords:  Helicobacter pylori; antibiotic; drug resistance; eradication

Year:  2022        PMID: 36172620      PMCID: PMC9512286          DOI: 10.2147/IDR.S383444

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.177


  22 in total

1.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

2.  Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies.

Authors:  Laisheng Luo; Yu Huang; Xiao Liang; Yingjie Ji; Lou Yu; Hong Lu
Journal:  Helicobacter       Date:  2020-05-19       Impact factor: 5.753

3.  Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection.

Authors:  Wen Zhong Liu; Yong Xie; Hong Lu; Hong Cheng; Zhi Rong Zeng; Li Ya Zhou; Ye Chen; Jiang Bin Wang; Yi Qi Du; Nong Hua Lu
Journal:  Helicobacter       Date:  2018-03-07       Impact factor: 5.753

4.  Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.

Authors:  Jing Ma; Miao Yu; Qiao-Qiao Shao; Xue-Chun Yu; Chen Zhang; Jun-Bo Zhao; Lin Yuan; Ya-Bin Qi; Ruo-Bing Hu; Pei-Ru Wei; Wei Xiao; Qi Chen; Bai-Ling Jia; Chuan-Liang Chen; Hong Lu; Song-Ze Ding
Journal:  Helicobacter       Date:  2022-06-15       Impact factor: 5.182

5.  Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community.

Authors:  Francis Megraud; Robin Bruyndonckx; Samuel Coenen; Linda Wittkop; Te-Din Huang; Martin Hoebeke; Lucie Bénéjat; Philippe Lehours; Herman Goossens; Youri Glupczynski
Journal:  Gut       Date:  2021-04-09       Impact factor: 23.059

6.  Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Ari Fahrial Syam; Iswan Abbas Nusi; Gontar Siregar; Marselino Richardo; Achmad Fuad Bakry; Yudith Annisa Ayu Rezkitha; I Dewa Nyoman Wibawa; Yoshio Yamaoka
Journal:  Infect Drug Resist       Date:  2019-01-31       Impact factor: 4.003

Review 7.  Treatment of Helicobacter pylori infection in the presence of penicillin allergy.

Authors:  Amit Kumar Dutta; Perminder Singh Phull
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

Review 8.  Primary Resistance Pattern of Helicobacter pylori to Antibiotics in Adult Population: A Systematic Review.

Authors:  Gebremicheal Gebreslassie Kasahun; Gebre Teklemariam Demoz; Desilu Mahari Desta
Journal:  Infect Drug Resist       Date:  2020-05-28       Impact factor: 4.003

9.  Association between Helicobacter pylori infection, eradication and diabetes mellitus.

Authors:  Masayuki Kato; Akiko Toda; Ritsuko Yamamoto-Honda; Yasuji Arase; Hirohito Sone
Journal:  J Diabetes Investig       Date:  2019-02-12       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.